Linked Learning Engagement: National Decision-making in the Introduction of New Vaccines

LOOK AT THIS IF YOU'RE INTERESTED IN:

Learning about Georgia’s experiences and lessons learned introducing the Rotavirus and Human Papillomavirus vaccines.

HOW CAN USE THIS MATERIAL:

Country stakeholders can use the lessons from Georgia’s experience to understand and determine considerations for the decision-making process for new vaccine introduction (NVI) and the key factors driving NVI decisions.

OVERVIEW:

Azerbaijan is missing both the Rotavirus and HPV vaccines in its national immunisation schedule and has not yet decided when to introduce these vaccines. The stakeholders from Azerbaijan’s Ministry of Health (MoH) indicated that there were no participatory, evidence-informed policy discussions around these two vaccines, and therefore, at the decision-making level, there may be an insufficient understanding of the rationale as well as implications associated with the introduction of these new vaccines. Meanwhile, Georgia has introduced both vaccines, undergoing a multifaceted and dynamic decision-making process, with the involvement of various influential stakeholders. The Linked Immunisation Action Network facilitated a discussion with Georgia immunisation and finance experts to support the MoH of Azerbaijan to learn from their neighboring country’s decision-making process for new vaccine introduction and the key factors driving their decisions.

Georgia’s Presentation – English

Brief – English

You May Also Like